120 related articles for article (PubMed ID: 7742044)
1. Highly attenuated HTLV type Ienv poxvirus vaccines induce protection against a cell-associated HTLV type I challenge in rabbits.
Franchini G; Tartaglia J; Markham P; Benson J; Fullen J; Wills M; Arp J; Dekaban G; Paoletti E; Gallo RC
AIDS Res Hum Retroviruses; 1995 Feb; 11(2):307-13. PubMed ID: 7742044
[TBL] [Abstract][Full Text] [Related]
2. Immunogenicity and protective efficacy of recombinant human T-cell leukemia/lymphoma virus type 1 NYVAC and naked DNA vaccine candidates in squirrel monkeys (Saimiri sciureus).
Kazanji M; Tartaglia J; Franchini G; de Thoisy B; Talarmin A; Contamin H; Gessain A; de Thé G
J Virol; 2001 Jul; 75(13):5939-48. PubMed ID: 11390595
[TBL] [Abstract][Full Text] [Related]
3. Highly attenuated HIV type 2 recombinant poxviruses, but not HIV-2 recombinant Salmonella vaccines, induce long-lasting protection in rhesus macaques.
Franchini G; Robert-Guroff M; Tartaglia J; Aggarwal A; Abimiku A; Benson J; Markham P; Limbach K; Hurteau G; Fullen J
AIDS Res Hum Retroviruses; 1995 Aug; 11(8):909-20. PubMed ID: 7492438
[TBL] [Abstract][Full Text] [Related]
4. Multiple immunizations with attenuated poxvirus HIV type 2 recombinants and subunit boosts required for protection of rhesus macaques.
Myagkikh M; Alipanah S; Markham PD; Tartaglia J; Paoletti E; Gallo RC; Franchini G; Robert-Guroff M
AIDS Res Hum Retroviruses; 1996 Jul; 12(11):985-92. PubMed ID: 8827214
[TBL] [Abstract][Full Text] [Related]
5. Head-to-Head Comparison of Poxvirus NYVAC and ALVAC Vectors Expressing Identical HIV-1 Clade C Immunogens in Prime-Boost Combination with Env Protein in Nonhuman Primates.
García-Arriaza J; Perdiguero B; Heeney J; Seaman M; Montefiori DC; Labranche C; Yates NL; Shen X; Tomaras GD; Ferrari G; Foulds KE; McDermott A; Kao SF; Roederer M; Hawkins N; Self S; Yao J; Farrell P; Phogat S; Tartaglia J; Barnett SW; Burke B; Cristillo A; Weiss D; Lee C; Kibler K; Jacobs B; Asbach B; Wagner R; Ding S; Pantaleo G; Esteban M
J Virol; 2015 Aug; 89(16):8525-39. PubMed ID: 26041302
[TBL] [Abstract][Full Text] [Related]
6. An HTLV-1 envelope mRNA vaccine is immunogenic and protective in New Zealand rabbits.
Tu JJ; King E; Maksimova V; Smith S; Macias R; Cheng X; Vegesna T; Yu L; Ratner L; Green PL; Niewiesk S; Richner JM; Panfil AR
J Virol; 2024 Feb; 98(2):e0162323. PubMed ID: 38193692
[TBL] [Abstract][Full Text] [Related]
7. Vaccination of rabbits with recombinant vaccinia virus carrying the envelope gene of human T-cell lymphotropic virus type I.
Hakoda E; Machida H; Tanaka Y; Morishita N; Sawada T; Shida H; Hoshino H; Miyoshi I
Int J Cancer; 1995 Feb; 60(4):567-70. PubMed ID: 7829272
[TBL] [Abstract][Full Text] [Related]
8. [Production of HTLV-II env protein and its suppressive effect on infection].
Kawamura N
Hokkaido Igaku Zasshi; 1995 Jul; 70(4):635-47. PubMed ID: 7590608
[TBL] [Abstract][Full Text] [Related]
9. Sequence analysis of an immunogenic and neutralizing domain of the human T-cell lymphoma/leukemia virus type I gp46 surface membrane protein among various primate T-cell lymphoma/leukemia virus isolates including those from a patient with both HTLV-I-associated myelopathy and adult T-cell leukemia.
Sherman MP; Dube S; Spicer TP; Kane TD; Love JL; Saksena NK; Iannone R; Gibbs CJ; Yanagihara R; Dube DK
Cancer Res; 1993 Dec; 53(24):6067-73. PubMed ID: 8261424
[TBL] [Abstract][Full Text] [Related]
10. A peptide-based human T cell leukemia virus type I vaccine containing T and B cell epitopes that induces high titers of neutralizing antibodies.
Baba E; Nakamura M; Ohkuma K; Kira J; Tanaka Y; Nakano S; Niho Y
J Immunol; 1995 Jan; 154(1):399-412. PubMed ID: 7527817
[TBL] [Abstract][Full Text] [Related]
11. Vaccination against canine distemper virus infection in infant ferrets with and without maternal antibody protection, using recombinant attenuated poxvirus vaccines.
Welter J; Taylor J; Tartaglia J; Paoletti E; Stephensen CB
J Virol; 2000 Jul; 74(14):6358-67. PubMed ID: 10864646
[TBL] [Abstract][Full Text] [Related]
12. Long-term persistence of protective immunity in cynomolgus monkeys immunized with a recombinant vaccinia virus expressing the human T cell leukaemia virus type I envelope gene.
Ibuki K; Funahashi SI; Yamamoto H; Nakamura M; Igarashi T; Miura T; Ido E; Hayami M; Shida H
J Gen Virol; 1997 Jan; 78 ( Pt 1)():147-52. PubMed ID: 9010298
[TBL] [Abstract][Full Text] [Related]
13. Head-to-head comparison on the immunogenicity of two HIV/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.
Gómez CE; Nájera JL; Jiménez EP; Jiménez V; Wagner R; Graf M; Frachette MJ; Liljeström P; Pantaleo G; Esteban M
Vaccine; 2007 Apr; 25(15):2863-85. PubMed ID: 17113200
[TBL] [Abstract][Full Text] [Related]
14. Generation and immunogenicity of novel HIV/AIDS vaccine candidates targeting HIV-1 Env/Gag-Pol-Nef antigens of clade C.
Gómez CE; Nájera JL; Jiménez V; Bieler K; Wild J; Kostic L; Heidari S; Chen M; Frachette MJ; Pantaleo G; Wolf H; Liljeström P; Wagner R; Esteban M
Vaccine; 2007 Mar; 25(11):1969-92. PubMed ID: 17224219
[TBL] [Abstract][Full Text] [Related]
15. Heterologous envelope immunogens contribute to AIDS vaccine protection in rhesus monkeys.
Letvin NL; Huang Y; Chakrabarti BK; Xu L; Seaman MS; Beaudry K; Korioth-Schmitz B; Yu F; Rohne D; Martin KL; Miura A; Kong WP; Yang ZY; Gelman RS; Golubeva OG; Montefiori DC; Mascola JR; Nabel GJ
J Virol; 2004 Jul; 78(14):7490-7. PubMed ID: 15220422
[TBL] [Abstract][Full Text] [Related]
16. Protection of rabbits against HTLV-II infection with a synthetic peptide corresponding to HTLV-II neutralization region.
Kariya N; Hayashi K; Hoshino H; Tanaka Y; Koirala TR; Ohara N; Miyamoto K; Akagi T
Arch Virol; 1996; 141(3-4):471-80. PubMed ID: 8645089
[TBL] [Abstract][Full Text] [Related]
17. Characterization of a B-cell immunodominant epitope of human T-lymphotropic virus type 1 (HTLV-I) envelope gp46.
Lairmore MD; Rudolph DL; Roberts BD; Dezzutti CS; Lal RB
Cancer Lett; 1992 Sep; 66(1):11-20. PubMed ID: 1360328
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to the envelope glycoprotein of human T cell leukemia virus type 1 robustly activate cell-mediated cytotoxic responses and directly neutralize viral infectivity at multiple steps of the entry process.
Kuo CW; Mirsaliotis A; Brighty DW
J Immunol; 2011 Jul; 187(1):361-71. PubMed ID: 21646298
[TBL] [Abstract][Full Text] [Related]
19. Induction of cytotoxic T lymphocytes by recombinant canarypox (ALVAC) and attenuated vaccinia (NYVAC) viruses expressing the HIV-1 envelope glycoprotein.
Cox WI; Tartaglia J; Paoletti E
Virology; 1993 Aug; 195(2):845-50. PubMed ID: 8337851
[TBL] [Abstract][Full Text] [Related]
20. Poxvirus-based Japanese encephalitis vaccine candidates induce JE virus-specific CD8+ cytotoxic T lymphocytes in mice.
Konishi E; Kurane I; Mason PW; Shope RE; Ennis FA
Virology; 1997 Jan; 227(2):353-60. PubMed ID: 9018134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
